Natixis Advisors, L.P. Global Cord Blood Corp Transaction History

Natixis Advisors, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$0.0 - $2.99 $0 - $708	-237 Reduced 0.12%	200,914 $211,000
Q3 2022 Nov 14, 2022	BUY	$2.05 - $3.0 $2,605 - $3,813	1,271 Added 0.64%	201,151 $601,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $3.98 $23,210 - $41,989	10,550 Added 5.57%	199,880 $592,000
Q1 2022 May 12, 2022	BUY	$3.74 - $4.55 $43,791 - $53,275	11,709 Added 6.59%	189,330 $729,000
Q4 2021 Feb 08, 2022	BUY	$3.9 - $4.75 $11,902 - $14,497	3,052 Added 1.75%	177,621 $744,000
Q3 2021 Nov 15, 2021	BUY	$4.57 - $5.39 $16,817 - $19,835	3,680 Added 2.15%	174,569 $815,000
Q1 2021 May 05, 2021	BUY	$3.8 - $4.92 $649,378 - $840,773	170,889 New	170,889 $774,000

44.8K

Ticker CO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 133,915,000
Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matchin...

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Natixis Advisors, L.P. with notifications on news.